Chapter 10
Schizophrenia
98 topics · 22 traps · 27 safety · 6 car scripts
- Scan must-know (one line per topic).
- Read every board trap and safety card.
- Quiz this chapter, then watch with study-along.
- Play car scripts in Speechify or read them here.
Chapter diagrams
Must know
Delusion subtypesDelusions are fixed false beliefs that persist despite conflicting evidence and represent 1 of the 5 core psychotic feature domains in the schizophrenia spectrum.
- Delusions are fixed false beliefs that persist despite conflicting evidence and represent 1 of the 5 core psychotic feature domains in the schizophrenia spectrum.
- The 6 primary delusion subtypes are persecutory (most common overall), referential, grandiose, erotomanic, nihilistic, and somatic.
- Delusions are classified as bizarre if they are physically impossible (such as alien abduction or organ removal without surgical scars) or non-bizarre if they involve plausible real-life scenarios (such as being spied on by police or cheated on by a partner).
- Under DSM-5-TR Criterion A for schizophrenia, at least 1 of the 2 required active symptoms must be delusions, hallucinations, or disorganized speech.
- Active psychotic symptoms must persist for at least 1 month, within a total continuous disturbance timeline of at least 6 months.
- Delusional disorder requires 1 or more delusions lasting for at least 1 month without marked social or occupational impairment outside the specific impact of the delusion.
Five Core Psychotic DomainsPsychosis involves clinical abnormalities across 5 primary feature domains: delusions, hallucinations, disorganized thinking (formal thought disorder), grossly disorganized or abnormal motor behavior (including catatonia), and negative symptoms.
- Psychosis involves clinical abnormalities across 5 primary feature domains: delusions, hallucinations, disorganized thinking (formal thought disorder), grossly disorganized or abnormal motor behavior (including catatonia), and negative symptoms.
- Delusions and hallucinations represent positive symptoms that reflect added pathological features during the active phase of illness.
- Disorganized thinking is inferred directly from formal speech patterns, presenting as derailment, loose associations, or tangentiality.
- Grossly disorganized motor behavior ranges from catatonic immobility to aimless agitation that disrupts daily self-care and activities of daily living.
- Negative symptoms reflect functional deficits, primarily diminished emotional expression (flat affect) and avolition (loss of self-initiated purposeful activity), which emerge in prodromal and residual phases and drive long-term disability.
Delusion Subtypes and Clinical FeaturesPersecutory delusions: The patient holds a fixed belief that they are being harmed, spied on, harassed, poisoned, or conspired against by external forces. This is the most prevalent delusion subtype in schizophrenia.
- Persecutory delusions: The patient holds a fixed belief that they are being harmed, spied on, harassed, poisoned, or conspired against by external forces. This is the most prevalent delusion subtype in schizophrenia.
- Referential delusions: The patient believes that neutral environmental events, public comments, television broadcasts, newspaper articles, or gestures from strangers have a direct, hidden personal meaning meant specifically for them.
- Grandiose delusions: The patient believes they possess exceptional abilities, unacknowledged talent, supreme wealth, fame, or a special relationship with a deity or famous persona.
- Erotomanic delusions: The patient falsely believes that another individual, usually a person of higher social standing, celebrity status, or authority, is deeply in love with them.
- Nihilistic delusions: The patient maintains a conviction that a major impending catastrophe will destroy the world, or that they themselves, their organs, or society no longer exist.
- Somatic delusions: The patient is preoccupied with ungrounded beliefs concerning bodily functions, physical health, or severe internal organ decay despite normal medical evaluations.
Diagnostic Timelines and Differential ComparisonSchizophrenia: Requires 2 or more Criterion A symptoms for at least 1 month (with at least 1 being delusions, hallucinations, or disorganized speech) and continuous disturbance signs lasting at least 6 months, accompanied by marked social or occupational decline.
- Schizophrenia: Requires 2 or more Criterion A symptoms for at least 1 month (with at least 1 being delusions, hallucinations, or disorganized speech) and continuous disturbance signs lasting at least 6 months, accompanied by marked social or occupational decline.
- Delusional disorder: Features 1 or more delusions lasting longer than 1 month. Crucially, social and occupational functioning is preserved outside the specific impact of the delusion, and core schizophrenia features like hallucinations or negative symptoms are absent or minimal.
- Brief psychotic disorder: Features acute psychotic symptoms lasting from 1 day to less than 1 month, followed by a complete return to premorbid functioning.
- Schizophreniform disorder: Features active schizophrenia symptom criteria lasting at least 1 month but less than 6 months, without requiring demonstrated social or occupational decline.
Safety AlertActive persecutory delusions or command auditory hallucinations in unmedicated patients elevate the risk of defensive agitation or violent outbursts. Conduct immediate risk assessments for harm to self or others.
- Active persecutory delusions or command auditory hallucinations in unmedicated patients elevate the risk of defensive agitation or violent outbursts. Conduct immediate risk assessments for harm to self or others.
- Suicide is attempted by 20% to 50% of individuals with schizophrenia, with a 5% lifetime completed suicide rate. Key risk factors include co-occurring major depressive episodes, command hallucinations, substance use, and preserved insight into functional deficits.
- Rule out organic medical etiologies (such as central nervous system tumors, temporal lobe epilepsy, HIV/AIDS, neurosyphilis, hypercalcemia, or steroid toxicity) before diagnosing primary psychosis.
Board TrapDo not mistake delusional disorder for schizophrenia. Patients with delusional disorder maintain normal functioning, grooming, and logic outside their specific delusional focus.
- Do not mistake delusional disorder for schizophrenia. Patients with delusional disorder maintain normal functioning, grooming, and logic outside their specific delusional focus.
- Do not pathologize culturally or religiously sanctioned beliefs. For instance, experiencing brief contact with the spirit of a recently deceased relative in accordance with cultural tradition is not a psychotic delusion.
- Do not confuse positive and negative symptoms when selecting pharmacotherapy. While both first-generation antipsychotics and second-generation antipsychotics treat positive symptoms like delusions, only second-generation antipsychotics demonstrate efficacy for negative symptoms due to serotonin receptor activity.
First-LineSecond-generation antipsychotics (SGAs) such as risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, or lurasidone are first-line pharmacotherapy for acute delusions and positive symptoms due to a lower risk of extrapyramidal symptoms and tardive dyskinesia compared to first-generation antipsychotics.
- Second-generation antipsychotics (SGAs) such as risperidone, olanzapine, quetiapine, aripiprazole, ziprasidone, or lurasidone are first-line pharmacotherapy for acute delusions and positive symptoms due to a lower risk of extrapyramidal symptoms and tardive dyskinesia compared to first-generation antipsychotics.
- First-episode psychosis warrants immediate referral to coordinated specialty care (CSC) programs to combine pharmacotherapy, psychotherapy, family education, and employment support.
Hallucinations vs normal statesHallucinations are vivid, clear perceptions occurring without an external stimulus that are not under voluntary control, with auditory hallucinations being the most common form in schizophrenia.
- Hallucinations are vivid, clear perceptions occurring without an external stimulus that are not under voluntary control, with auditory hallucinations being the most common form in schizophrenia.
- Hypnagogic (falling asleep) and hypnopompic (waking up) hallucinations occur during normal sleep-wake transitions and represent non-psychotic physiological phenomena.
- DSM-5-TR diagnosis of schizophrenia requires at least 2 characteristic symptoms for a 1-month active phase, and at least 1 symptom must be delusions, hallucinations, or disorganized speech.
- Continuous signs of disturbance in schizophrenia must persist for at least 6 months, whereas brief psychotic disorder lasts 1 day to less than 1 month, and schizophreniform disorder lasts 1 month to less than 6 months.
- Non-psychotic visual hallucinations in elderly patients with vision loss from macular degeneration or diabetic retinopathy represent Charles Bonnet syndrome, where patients remain alert, lucid, and aware the images are not real.
- Culturally sanctioned experiences, such as perceiving or communicating with a recently deceased loved one during normal grief, are non-pathological and do not constitute a psychotic disorder.
Five Core Psychotic Domains and Hallucination MechanicsHallucinations are defined as perception-like experiences that occur without an external stimulus. They are vivid and clear, holding the full force and impact of real perceptions, and are not under voluntary control. While hallucinations can occur in any sensory modality (auditory, visual, tactile, gustatory, or synesthetic), auditory hallucinations are by far the most frequent in schizophrenia and related psychotic disorders.
- Hallucinations are defined as perception-like experiences that occur without an external stimulus. They are vivid and clear, holding the full force and impact of real perceptions, and are not under voluntary control. While hallucinations can occur in any sensory modality (auditory, visual, tactile, gustatory, or synesthetic), auditory hallucinations are by far the most frequent in schizophrenia and related psychotic disorders.
- Hypnagogic hallucinations occur while falling asleep.
- Hypnopompic hallucinations occur while waking up.
- Both hypnagogic and hypnopompic experiences occur during normal sleep-wake transitions and must never be diagnosed as primary psychosis or schizophrenia.
Auditory Hallucinations in SchizophreniaThink: True primary psychotic perception.
- Think: True primary psychotic perception.
- Priority: Assess for command content and immediate safety risk.
- Boards are testing: Required core diagnostic criterion for schizophrenia requiring at least a 1-month active phase within a 6-month total disturbance.
Hypnagogic and Hypnopompic HallucinationsThink: Normal sleep-wake transition phenomena.
- Think: Normal sleep-wake transition phenomena.
- Priority: Reassure patient; no psychotropic intervention required.
- Boards are testing: Differentiating normal neurophysiology from primary psychiatric pathology.
Charles Bonnet SyndromeThink: Release visual hallucinations secondary to ocular vision loss.
- Think: Release visual hallucinations secondary to ocular vision loss.
- Priority: Ophthalmologic evaluation and patient reassurance.
- Boards are testing: Medical mimic of visual hallucinations in elderly patients with preserved insight and cognition.
Culturally Sanctioned Bereavement ExperiencesThink: Culturally normative grief response.
- Think: Culturally normative grief response.
- Priority: Validate cultural context; avoid premature psychotropic prescribing.
- Boards are testing: Avoiding false-positive diagnoses of brief psychotic disorder.
Positive Symptoms versus Negative SymptomsThink: Added pathological experiences versus deficits in normal function.
- Think: Added pathological experiences versus deficits in normal function.
- Priority: Positive symptoms (hallucinations, delusions) respond well to antipsychotics; negative symptoms (avolition, flat affect) cause profound long-term disability and respond better to SGAs.
- Boards are testing: SGAs modulate 5-HT2A and D2 receptors to better address negative symptoms compared to FGAs.
Common Board Traps and Clinical Safety SignpostsSecond-generation antipsychotics (SGAs) such as risperidone, olanzapine, or quetiapine are first-line pharmacotherapy for acute active-phase hallucinations and delusions due to lower EPS risk compared to first-generation antipsychotics (FGAs).
- Diagnosing schizophrenia in an elderly patient presenting with new-onset isolated visual hallucinations. Late-onset primary schizophrenia after age 60 is extremely rare. Always rule out medical causes, drug toxicity, delirium, or visual release phenomena like Charles Bonnet syndrome.
- When evaluating a patient with active hallucinations, always assess for command auditory hallucinations instructing self-harm or violence. Violent episodes in untreated schizophrenia are frequently driven by response to active hallucinations or severe persecutory delusions.
- Second-generation antipsychotics (SGAs) such as risperidone, olanzapine, or quetiapine are first-line pharmacotherapy for acute active-phase hallucinations and delusions due to lower EPS risk compared to first-generation antipsychotics (FGAs).
Board trap. Diagnosing schizophrenia in an elderly patient presenting with new-onset isolated visual hallucinations. Late-onset primary schizophrenia after age 60 is extremely rare. Always rule out medical causes, drug toxicity, delirium, or visual release phenomena like Charles Bonnet syndrome.
Safety. When evaluating a patient with active hallucinations, always assess for command auditory hallucinations instructing self-harm or violence. Violent episodes in untreated schizophrenia are frequently driven by response to active hallucinations or severe persecutory delusions.
Which of the following statements is false regarding schizophrenia and safety risks?A. A violent episode in schizophrenia can occur in response to a hallucination.
- A. A violent episode in schizophrenia can occur in response to a hallucination.
- B. The presence of a major depressive disorder episode increases the risk of a suicide attempt in schizophrenia.
- C. Suicide is attempted by up to 50% of patients with schizophrenia.
- D. Patients with schizophrenia who are receiving treatment are more likely to commit homicide than members of the general public.
Board traps
Common Board Traps and Clinical Safety Signposts
Diagnosing schizophrenia in an elderly patient presenting with new-onset isolated visual hallucinations. Late-onset primary schizophrenia after age 60 is extremely rare. Always rule out medical causes, drug toxicity, delirium, or visual release phenomena like Charles Bonnet syndrome.
Signposts
Test items often present a patient who is quiet, withdrawn, and lacking eye contact, tempting test-takers to diagnose primary major depressive disorder. If the stem describes thought blocking, gradual decline in ADLs over six months, or residual phase findings without prominent depressive mood, the primary diagnosis is schizophrenia with predominant negative symptoms.
Board Traps to Avoid
Prematurely diagnosing schizophrenia when symptoms have lasted less than 6 months. Always select schizophreniform disorder if the timeline is between 1 and 6 months.
Schizoaffective Disorder vs. Mood Disorder with Psychotic Features
Misdiagnosing schizophrenia in a patient who has concurrent manic or depressive episodes without verifying whether psychotic symptoms occur independently for at least 2 weeks without mood symptoms.
First-Line Antipsychotic Selection and Receptor Dynamics
Do not confuse local clinic prescribing habits with national examination standards. On board exams, FGAs are never first-line choices unless a patient has a documented history of excellent response and minimal side effects on an FGA in the past.
Treatment-Resistant Psychosis and Clozapine Management
Tobacco smoking induces the CYP1A2 enzyme through aromatic hydrocarbons in smoke, not through nicotine itself. Because clozapine and olanzapine are CYP1A2 substrates, smoking lowers their serum concentrations. If a patient on clozapine is hospitalized and forced to stop smoking, their clozapine level will rise rapidly, increasing the risk of seizures, severe orthostasis, and respiratory depression.
Clinical Signposts and Strategic Exam Rules
Assuming normal baseline laboratory values eliminate the need for follow-up testing. The exam tests whether you recheck fasting glucose and lipid profiles at the 3-month mark regardless of normal baseline results.
Treatment Strategies for EPS
Keeping patients on long term anticholinergics like benztropine can cause severe anticholinergic toxicity and cognitive decline. Anticholinergic drugs should be maintained at the lowest effective dose for the shortest necessary duration and reassessed for discontinuation after weeks to months.
Safety alerts
Common Board Traps and Clinical Safety Signposts
When evaluating a patient with active hallucinations, always assess for command auditory hallucinations instructing self-harm or violence. Violent episodes in untreated schizophrenia are frequently driven by response to active hallucinations or severe persecutory delusions.
Signposts
Negative symptoms like severe avolition and asociality often lead to profound self-neglect, poor grooming, or failure to manage co-occurring medical conditions such as type 2 diabetes or cardiovascular disease. Always assess self-care capability and ADL execution.
Duration-based differential diagnoses
Always rule out substance-induced psychotic disorder and medical causes such as delirium, neurodegenerative conditions, or metabolic abnormalities before diagnosing a primary psychotic disorder.
First-Line Antipsychotic Selection and Receptor Dynamics
SGAs carry a significant risk for metabolic syndrome. Olanzapine and clozapine produce the highest risk of weight gain, dyslipidemia, and new-onset diabetes. Quetiapine produces marked sedation and weight gain. Ziprasidone is metabolic-neutral but carries the highest risk of QTc prolongation among SGAs and must be taken with a meal of at least 500 calories for proper absorption. Aripiprazole acts as a D2 partial agonist, resulting in minimal metabolic disturbance but an increased incidence of akathisia.
Treatment-Resistant Psychosis and Clozapine Management
Clozapine carries a 1% to 2% risk of life-threatening agranulocytosis. Baseline ANC must be checked prior to initiation and must be at least 1,500/mm3 for the general population or at least 1,000/mm3 for individuals with documented benign ethnic neutropenia. The monitoring schedule requires weekly blood draws for 6 months, biweekly draws for the next 6 months, and monthly draws thereafter for the duration of treatment. Therapy must be interrupted if the ANC drops below 1,000/mm3.
Neuroleptic Malignant Syndrome
Neuroleptic Malignant Syndrome is a life-threatening medical emergency with a 10% to 20% mortality rate. It can occur within 45 minutes to 65 days after starting or increasing an antipsychotic, or when rapidly switching agents. Risk factors include rapid dose escalation, parenteral administration, physical exhaustion, dehydration, and co-administration of lithium.
High-Yield Concept Map: Metabolic Monitoring Protocol
Second-generation antipsychotics can trigger rapid-onset diabetic ketoacidosis (DKA) or severe hyperglycemic hyperosmolar state, even in patients without a prior diagnosis of diabetes.
Clinical Signposts and Strategic Exam Rules
clozapine and olanzapine carry black box warnings and high clinical alerts for severe metabolic disruption, requiring vigilant tracking of fasting glucose and lipid parameters.
Compare and distinguish
Neurochemical and Neuroanatomical Etiology
- Positive symptoms vs Negative symptoms:
- Positive symptoms: Delusions, hallucinations, disorganized speech, bizarre motor behavior. These represent additions to normal perception. Present during active phases. Well-controlled by both first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs).
- Negative symptoms: Avolition, flat affect, alogia (poverty of speech), thought blocking, social withdrawal, decreased eye contact. These represent deficits in normal functioning. Present during prodromal and residual phases. Highly disabling over time. Poorly controlled by FGAs, better managed by SGAs.
Memory hooks
No memory hooks in this pack.
Car scripts
- Drive 1 of 6~28 min · 4242 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 1 of 6.
- Drive 2 of 6~26 min · 3853 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 2 of 6.
- Drive 3 of 6~36 min · 5360 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 3 of 6.
- Drive 4 of 6~40 min · 5948 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 4 of 6.
- Drive 5 of 6~39 min · 5819 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 5 of 6.
- Drive 6 of 6~21 min · 3193 wordsFitzgerald PMHNP board review. ch10. Schizophrenia. This is drive 6 of 6.